FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3046148497> ?p ?o ?g. }

• W3046148497 abstract "Background Hemophagocytic lymphohistiocytosis (HLH) can be familial or secondary, which is often triggered by infection or malignancy. HLH therapy includes dexamethasone and etoposide. However, therapy is associated with significant morbidity and mortality. Anakinra, a recombinant interleukin-1 receptor antagonist, has been reported to treat macrophage activation syndrome (MAS), rheumatic sHLH. We report our experience with anakinra to treat patients with nonrheumatic secondary HLH (sHLH). Procedure Six children were diagnosed with HLH from December 2014 to August 2016 and were treated with subcutaneous anakinra (6-10 mg/kg/day divided over four doses) with or without dexamethasone (10 mg/m2 /day). Therapy was either escalated or weaned based on clinical and laboratory response. Results Five of six patients were treated with anakinra and dexamethasone, and one with anakinra alone due to active cytomegalovirus (CMV) pneumonitis. The median age of diagnosis was 1.8 years (range 0.8-14.9 years). No pathogenic mutations associated with HLH were identified, but three of six possessed genetic variants of unknown significance. Infectious triggers were identified for four patients and two patients had malignancies. The average treatment duration was 8 weeks with 3.5-5.5 years of follow up. No patient needed escalation of therapy to include etoposide. All patients achieved remission. Anakinra was well tolerated without significant adverse effects. Conclusion Initial treatment with anakinra (with or without dexamethasone) is a feasible treatment alternative for patients with secondary HLH and may allow for avoidance of etoposide. We recommend early initiation of anakinra when HLH is suspected. A broader investigation of the use of anakinra as a first-line agent for HLH is ongoing." @default.
• W3046148497 created "2020-08-03" @default.
• W3046148497 creator A5016125425 @default.
• W3046148497 creator A5018471006 @default.
• W3046148497 creator A5024893110 @default.
• W3046148497 creator A5042033528 @default.
• W3046148497 creator A5044759942 @default.
• W3046148497 creator A5049542589 @default.
• W3046148497 creator A5084751957 @default.
• W3046148497 creator A5085891291 @default.
• W3046148497 date "2020-07-29" @default.
• W3046148497 modified "2023-10-05" @default.
• W3046148497 title "The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis" @default.
• W3046148497 cites W1968057560 @default.
• W3046148497 cites W2055212747 @default.
• W3046148497 cites W2068039357 @default.
• W3046148497 cites W2076186742 @default.
• W3046148497 cites W2081414355 @default.
• W3046148497 cites W2088301075 @default.
• W3046148497 cites W2088525451 @default.
• W3046148497 cites W2105957247 @default.
• W3046148497 cites W2117912424 @default.
• W3046148497 cites W2125518260 @default.
• W3046148497 cites W2155477306 @default.
• W3046148497 cites W2169555023 @default.
• W3046148497 cites W2219680927 @default.
• W3046148497 cites W2273799513 @default.
• W3046148497 cites W2319669596 @default.
• W3046148497 cites W2739767001 @default.
• W3046148497 cites W2757190301 @default.
• W3046148497 cites W2920958771 @default.
• W3046148497 cites W2949590331 @default.
• W3046148497 cites W2973124663 @default.
• W3046148497 cites W3023566105 @default.
• W3046148497 doi "https://doi.org/10.1002/pbc.28581" @default.
• W3046148497 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32725881" @default.
• W3046148497 hasPublicationYear "2020" @default.
• W3046148497 type Work @default.
• W3046148497 sameAs 3046148497 @default.
• W3046148497 citedByCount "39" @default.
• W3046148497 countsByYear W30461484972020 @default.
• W3046148497 countsByYear W30461484972021 @default.
• W3046148497 countsByYear W30461484972022 @default.
• W3046148497 countsByYear W30461484972023 @default.
• W3046148497 crossrefType "journal-article" @default.
• W3046148497 hasAuthorship W3046148497A5016125425 @default.
• W3046148497 hasAuthorship W3046148497A5018471006 @default.
• W3046148497 hasAuthorship W3046148497A5024893110 @default.
• W3046148497 hasAuthorship W3046148497A5042033528 @default.
• W3046148497 hasAuthorship W3046148497A5044759942 @default.
• W3046148497 hasAuthorship W3046148497A5049542589 @default.
• W3046148497 hasAuthorship W3046148497A5084751957 @default.
• W3046148497 hasAuthorship W3046148497A5085891291 @default.
• W3046148497 hasConcept C126322002 @default.
• W3046148497 hasConcept C177713679 @default.
• W3046148497 hasConcept C187212893 @default.
• W3046148497 hasConcept C2779079688 @default.
• W3046148497 hasConcept C2779134260 @default.
• W3046148497 hasConcept C2781228260 @default.
• W3046148497 hasConcept C71924100 @default.
• W3046148497 hasConceptScore W3046148497C126322002 @default.
• W3046148497 hasConceptScore W3046148497C177713679 @default.
• W3046148497 hasConceptScore W3046148497C187212893 @default.
• W3046148497 hasConceptScore W3046148497C2779079688 @default.
• W3046148497 hasConceptScore W3046148497C2779134260 @default.
• W3046148497 hasConceptScore W3046148497C2781228260 @default.
• W3046148497 hasConceptScore W3046148497C71924100 @default.
• W3046148497 hasIssue "11" @default.
• W3046148497 hasLocation W30461484971 @default.
• W3046148497 hasOpenAccess W3046148497 @default.
• W3046148497 hasPrimaryLocation W30461484971 @default.
• W3046148497 hasRelatedWork W2114702694 @default.
• W3046148497 hasRelatedWork W2318655363 @default.
• W3046148497 hasRelatedWork W2973124663 @default.
• W3046148497 hasRelatedWork W3046148497 @default.
• W3046148497 hasRelatedWork W3103617805 @default.
• W3046148497 hasRelatedWork W3118337072 @default.
• W3046148497 hasRelatedWork W3134346061 @default.
• W3046148497 hasRelatedWork W3151213682 @default.
• W3046148497 hasRelatedWork W4255511859 @default.
• W3046148497 hasRelatedWork W4303710110 @default.
• W3046148497 hasVolume "67" @default.
• W3046148497 isParatext "false" @default.
• W3046148497 isRetracted "false" @default.
• W3046148497 magId "3046148497" @default.
• W3046148497 workType "article" @default.